Skip to main content
. 2023 Aug;15(4):503–512. doi: 10.18502/ijm.v15i4.13504

Table 3.

Antibiotic susceptibility pattern of E. coli species isolates.

Antimicrobial Agentes Disk concentration Diameter inhibition %R %I %S

Resistant Susceptible
Amikacin 30 ≤14 ≥17 6.5 - 93.5
Amp/Sulbactam 10 ≤11 ≥15 35.5 20.5 31.8
Ampicilin 10 ≤13 ≥17 67.8 - 32.2
Aztreonam 30 ≤15 ≥22 38.7 6.5 54.8
Cefazolin 30 ≤14 ≥18 42 3.2 54.8
Cefepime 30 ≤14 ≥18 41.9 - 58.1
Cefotaxime 30 ≤14 ≥23 38.7 - 65.3
Cefoxitin 30 ≤14 ≥18 6.5 3.2 90.3
Ceftazidime 30 ≤14 ≥18 38.7 - 61.3
Ceftriaxone 30 ≤13 ≥21 35.5 3.2 61.3
Ciprofloxacin 5 ≤15 ≥21 41.9 - 58.1
Doripenem 8 ≤13 ≥21 3.2 - 96.8
Ertapenem 4 ≤15 ≥21 3.2 - 96.8
Gentamicin 10 ≤12 ≥15 22.6 - 77.4
Meropenem 10 ≤13 ≥16 6.5 - 93.5
Nitrofurantoin 300 ≤14 ≥17 6.5 - 93.5
Pip/tazo 100/10 ≤17 ≥21 22.5 6.5 71.3
Piperacilin 100 ≤17 ≥21 45.2 - 54.8
Tobramycin 10 ≤12 ≥15 19.3 9.7 71
Trimet/sulfa 0.25/23.7 ≤10 ≥16 50 - 50